10 weeks
for go-live
20+
COE resources
100%
Regulatory and timeline compliance
US based TOP 10 pharma company required support in preparation and filing of the eCTD/CTD submissions in US, EU and ASEAN markets
Client had limited regulatory resources / experience to prepare, publish and file regulatory dossiers
Product portfolio included 2 groups – drugs and CHC products
Service portfolio included several individual and grouped variations
Dedicated CoE across multiple geographies with US based Program Director and EU based Client Servicing Manager
2 onshore and 18 FTEs offshore, including Regulatory Specialists, Associates, QC and Program managers
Regulatory database management, dossiers creation, compiling per local requirements, publishing and final updates to the RIMS
Facilitate the approval process by effective coordination with headquarters, local affiliates and manufacturing sites.
Lead time of only 10 weeks from contract signing to training, on-boarding and go-live
Reuse of documents for other submissions and updates.
28% effort efficiencies delivered within 1 year of engagement
Consistently good feedback from the Client with discussion on expansion into other service areas
A Major Global Pharmaceutical company required regulatory submission support in the preparation of Clinical Trial Applications (CTAs) and Submissions in multiple countries within Europe.
The scope of services included
Preparation & planning of CTAs
Review & Submission of CTAs
Clinical Trial Lifecycle Support and follow-up
Regulatory intelligence on the CTA document requirements in various countries
*UK, Belgium, France , Germany, Sweden
Indegene set up a 5 member team of regulatory writers with extensive experience in understanding the complex country-specific and local regulatory requirements.
Developed a robust Implementation plan to quickly achieve steady state and a strong QC and communication process to track KPIs
The team carried out the following activities
Preparation/review of CTA dossier plans
Robust review aligned with competent authorities and sponsor requirements
Early identification of deficiencies
Effortless navigation of the submission systems used by different countries
Provide support during the phase of authority review and query resolution
Handling of all substantial and non-substantial amendments
Maintain records of all regulatory steps, particular correspondence and applicable documentation
Robust review and timely communication helped guide the client through the European approval process avoiding too many queries or formal deficiencies from competent authorities
Accurate interpretation of the regulatory environment and submission scenarios resulted in compliance to regulatory timelines and international standards.
50+
Trials
100%
Compliant - SOP, Quality, and Timelines
20+
Client POCs
3+ Years
Engagement
CVS clinical research team wanted clinical trial registration and results disclosure support
Actively track and advise on potential impact of key regulatory reforms
Help them align with the evolving guidelines and regulations.
Regulatory and clinical experts deployed for managing Regulatory compliance.
Comprehensive disclosure reporting in a centralized, cost-effective manner.
Tracking, assessments, document management, summarization, release information to registries, registry query, and monthly site/status updates.
100% accurately and compliance with minimal sponsor management
Scalable, flexible, cost-effective model
Pharma company is developing a combination drug formulation to be launched successfully in brazil and Mexico. Company wants to have a thorough understanding of regulatory market scenario in the countries
To provide an in-depth analysis of the Brazilian and Mexican markets and their regulatory environment in order to successfully launch of the drug for a neurological disorder.

Indegene executed this project through secondary research (using any data available on the public domain such as country specific regulatory websites, healthcare databases etc.) and Key Opinion Leader (KOL) interviews with emphasis on the following key intelligence topics providing the Overall market scenario
Factors influencing the launch of new drugs in Brazil and Mexico
Pricing and reimbursement scenario
Healthcare coverage and spending (Private versus Government.)
Regulatory environment including the regulatory pathways
Two comprehensive reports providing the insights on the regulatory and the market scenario was provided which helped the company to understand the regulatory pathway

30+
CSRs (Full & Abbreviated)
100%
Compliance
3+ Years
Engagement
A major biopharmaceutical company required regulatory writing management & support for Clinical Study Reports (CSR) of their studies (including pivotal trials) in US and the EU
Indegene deployed a dedicated team of experienced senior regulatory writers with extensive therapeutic knowledge (such as cardiovascular, reproductive medicine & gynaecology, immunology, and oncology) & understanding of the drug development process as per ICH standards
The team worked in close collaboration with the customer to communicate requirements & progress against timelines, and ensure all quality controls are met.
Our in-house biostatisticians, clinical research experts and medical reviewers worked together with our medical writers to produce high quality clinical reports, with specially formatted tables and charts and detailed custom graphics.
In addition, a rigorous quality assurance process was implemented to ensure all clinical study reports are accurate, complete, and in compliance with regulatory and ICH standards.
The CSRs were submitted to the appropriate regulatory agencies as per the agreed due date in compliance with ICH standards
Indegene consistently provided high-quality reports by adopting a sustainable, cost-effective,& flexible working model solutions that reduced the need for additional review and re-work and helped our customer to crystallize the essential results that regulators need to know
The prepared CSRs helped optimize and streamline the preparation of ensuing CTDs, thus saving customer time and money spent by 20%
20+
CSRs (Synopsis and Supplemental)
100%
Compliance
2+ Years
Engagement
A major biopharmaceutical company required the support of Indegene to coordinate and author high quality Clinical Study Reports (CSR) for regulatory submission in the APAC region
A dedicated team of local and remote medical writers for authoring and QC was deployed who had extensive domain expertise & understanding of the drug development process as per country specific regulatory standards within APAC
The medical writers worked in collaboration with the biostatisticians, clinical research experts, medical reviewers and regulatory publishers to produce consistently high quality submission-ready clinical reports that met regulatory expectations.
A rigorous quality assurance process was implemented to ensure all clinical study reports are accurate, complete, and in PDF format with all necessary bookmarks and hyperlinks set to the correct destination PTT tables.
Delivered consistent and measurable high quality reports that met regulatory expectations.
A winning combination of a dedicated team and flexible support, enabled large volume of documents to be generated on time and within budget. The client continues to remain a long-term partner.
Trusted by all 20 of the world's top 20 pharmaceutical companies, Indegene helps life sciences organizations accelerate outcomes across the entire value chain.